Recruiting
Phase 3

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Sponsor:

Novo Nordisk A/S

Code:

NCT05021835

Conditions

Cardiovascular Risk

Chronic Kidney Disease

Inflammation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab B

Ziltivekimab C

Placebo (Ziltivekimab B)

Placebo (Ziltivekimab C)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information